Tranexamic acid lowers transfusion requirements and hospital length of stay following revision total hip or knee arthroplasty

BACKGROUD: Intravenous tranexamic acid (TXA) has been shown to reduce blood loss in patients undergoing total joint arthroplasty without systemic complications. There is limited evidence of its effectiveness in revision procedures. This study evaluated intravenous TXA effect on blood loss, transfusi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Patient Saf Surg
Hlavní autoři: Gianakos, Arianna L., Saad, Bishoy N., Haring, Richard, Menken, Luke G., Elkattaway, Sherif, Liporace, Frank A., Yoon, Richard S.
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2021
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8111901/
https://ncbi.nlm.nih.gov/pubmed/33975621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13037-021-00295-5
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky